Onward Medical announced today that it received FDA 510(k) clearance to expand the ARC-EX system's indication for home use.

Researchers at Northwestern University have developed a “breakthrough” new therapy to help paralyzed mice walk again that could result in a potentially life-changing treatment for humans. Scientists ...

Initial research indicates that Perineline TM, which received Orphan Drug Designation in 2022 may improve neuroplasticity and neuroregeneration to enable new synapses to be made. Pre-clinical data ...

New therapy being developed by a father and son-led team of experts could potentially improve patient mobility outcomes for spinal paralysis. The grounding research of highly regarded neuro glyco ...

Ninety percent of paralyzed patients regained strength or function in their upper limbs after receiving an experimental therapy, a new study found. After receiving spinal cord simulation from ONWARD ...

Northwestern Medicine investigators have developed a new imaging approach to more accurately assess blood flow in the spinal ...

The US Food and Drug Administration (FDA) has granted 510 (k) clearance for the expanded use of Onward Medical’s ARC-EX System, now permitting individuals with spinal cord injuries (SCI) to use the ...

NervGen's NVG-291 shows promising preclinical results in spinal cord injury, with significant improvements in motor function and nerve regeneration, positioning it as a potential breakthrough in ...

LOS ANGELES -- A 25-year-old Los Angeles man paralyzed from the waist down after being hit by a car in 2006 has regained the ability to stand, take steps on a treadmill and move his hips, knees, ...

Diabetic peripheral neuropathy is a debilitating, progressive neurologic disorder that affects about 30% of adults with diabetes. Spinal cord stimulation is a newer option for addressing moderate to ...